Article
Unlike arginine vasopressin, the selective V1a receptor agonist FE 202158 does not cause…
Critical care medicine · 2012 · P. Enkhbaatar, N. Ferdyan, E. La, R. Laporte, S. Qi, S. Rehberg, J. Rehberg, PJ. Riviere, CD. Schteingart, LD. Traber, DL. Traber, K. Wisniewski
Key facts
| Title | Unlike arginine vasopressin, the selective V1a receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor. |
|---|---|
| First author | P. Enkhbaatar, N. Ferdyan, E. La, R. Laporte, S. Qi, S. Rehberg, J. Rehberg, PJ. Riviere, CD. Schteingart, LD. Traber, DL. Traber, K. Wisniewski |
| Journal | Critical care medicine |
| Published | Jun 1, 2012 |
| DOI | 10.1097/ccm.0b013e31824e0fe5 |
| PubMed ID | 22488005 |
| PMC ID | PMC7461604 |
| Devices mentioned | 202158 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1